The team, consisting of Philip Mitchell, Gordon Parker, Peter Schofield and Michael Breakspear, received $7 million over five years from the NHMRC for the program "Depressive and bipolar disorders: Pathophysiology, phenotypes and treatment innovations". This research program aims to further our knowledge of the causes and presentations of the mood disorders, and to improve and tailor treatment for the many Australians who suffer from these highly disabling illnesses. |